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Abstract- Aluminum phosphide poisoning (ALPP) still has no efficient and approved antidote. Supportive 
care and hemodynamic monitoring are the only choices of treatment. We proposed a new lavage formulation 
in addition to evaluation of its efficacy and defining the impact of clinical characteristics of patients on their 
prognosis. During eight months period of time, 120 patients were enrolled to the study and randomly received 
two different gastric lavage protocols. Our new lavage protocol had positive impact on patients’ survival and 
the P-value in comparison with the classic gastric lavage method was close to significant level (P=0.054). On 
hospital arrival indication for intubation-ventilation as well as sense of thirst, sore throat and absence of 
nausea indicate worse outcome. Using our novel approach, indication for intubation-ventilation as well as 
sense of thirst, sore throat and absence of nausea can be considered as applicable prognostic factors in 
survival of ALPP patients. Further studies are required to set this approach as preferred treatment.  
© 2012 Tehran University of Medical Sciences. All rights reserved.  
Acta Medica Iranica, 2012; 50(8): 530-534. 
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Introduction 
 
Aluminum phosphide poisoning (ALPP) is common in 
Asia, especially in India, Jordan, Morocco and Iran due 
to its frequent use as a fumigant in grain storage 
facilities. In parallel with its accidental ingestion, it has 
been used frequently as a suicidal agent as well (1-5). 
Apart from that, there is neither a potent antidote nor an 
effective treatment approach has been yet established for 
ALPP and supportive care such as correction of 
metabolic acidosis, hypokalemia and hypoglycemia in 
addition to monitoring blood pressure and cardiac output 
is the only choice of treatment which should be executed 
when necessary by clinical developments (6-10).  
In Iran, however, gastric lavage is a standard 
treatment especially in our center. Although no protocol 
for gastric lavage has been well defined yet, oral 
administration of sodium bicarbonate, lavage of 
potassium permanganate, activated charcoal and 
vegetable oils are of the recommended first line 
approaches to ALPP by few authors (3,11,12). This is to 
decrease the toxin absorption and alkalize blood pH as a 
compensatory attempt for the inevitable metabolic 
acidosis (3,11,12).  
Nevertheless, many patients die in spite of intensive 
care and therefore, establishment of new treatment 
strategy has been always in demand. Thus, in this paper, 
we demonstrated a novel technique as a primary 
approach to patients with ALPP due to intentional 
ingestion of aluminum phosphide tablets. Furthermore, 
we compared them to patients treated using local classic 
method of potassium permanganate lavage followed by 
oral administration of sodium bicarbonate.   
 
Patients and Methods 
 
We conducted this cohort study in Loghman Hakim 
Poison Hospital (Tehran, Iran) which is a referral center 
of poisoning in Iran and a center of excellence in Middle 
East. Between April and November 2009 and after 
institutional approval for ethics, all cases of ALPP who 
had intended to commit suicide were considered for the 
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study. Amongst them all, patients who: came into the 
hospital no later than two hours from ingestion, had no 
vomit after ingestion for one hour, did not solve the 
pill(s)in water prior to ingestion and had positive silver 
nitrate test of gastric fluid were enrolled to the study. In 
contrast, all cases with mixed drug-aluminum phosphide 
poisoning, chronic toxicity, negative or suspicious silver 
nitrate test, unknown count of ingested aluminum 
phosphide tablets and whose time of hospital arrival was 
longer than two hours (from ingestion time) were 
excluded. 
Then from all patients admitted to the emergency 
ward for poisoning, total number of 120 patients (67 
males, 53 females; mean age 27.4) best fit the inclusion 
criteria. These patients were allocated into two groups 
randomly while none of the patients or clinical staff was 
aware of therapeutic materials in detail. Patients, in 
whom intubation was necessary, were considered for 
mechanical ventilation immediately.  
First group (control group, Table 1) comprised 60 
patients (31 males, 29 females; mean age 26.4) to whom 
potassium permanganate (1:10000) lavage and oral 
administration of three vials of sodium bicarbonate 
(7.5%) via gastric tube were considered (PS). This is 
actually the classic technique of our center in which, as 
well as the rest of the world, no efficient antidote is 
available and charcoal is usually not considered unless 
for cases of drug overdose regardless of ALPP. The 
second group (Table 1) comprised other 60 patients (36 
males, 24 females; mean age 26.4) who received the 
new protocol performed as follows: suction of gastric 
contents using a 50 ml syringe, oral administration of 
three vials of sodium bicarbonate, potassium 
permanganate (1:10000) lavage and oral administration 
of three vials of sodium bicarbonate (SSPS) once again.  
 
Table 1. Age average and number of patients in each of PS 
and SSPS group for gender. 
  patients 
n 
age average  
years 
Male  PS 31 26,06 26 
SSPS 36 25.94 
Female  PS 29 26.72 26.77 
SSPS 24 26.83 
n: number 
 
For each patient the following specifications were 
recorded: age, sex, number of ingested tablets, presented 
epigastric pain, nausea, sore throat, heartburn, dyspnea, 
sense of thirst, necessity of mechanical ventilation on 
hospital arrival, past history of psychological disorder 
and past suicidal attempts. In contrast, liver and kidney 
function tests, pathologic evaluation and autopsy were 
not considered due to the specific design of the study. 
When necessary, volume expanders, positive 
inotropes, pulse oximetry, nasal oxygen therapy were 
provided.  
All gathered data were transferred to SPSS 17 
Software and Chi-Square and t-test were used for 
analysis. Statistical significance level was set as 0.05 or 
less.  
 
Results 
 
For both SP and SSPS groups, comparison regarding 
age, sex, indication of intubation, dyspnea, number of 
ingested pills, presence of epigastric pain, heart burn, 
sore throat, sense of thirst, nausea, past history of 
psychological disorders, past history of suicidal 
attempt(s) and number of attempts with frequency of 
mortality was performed and results are summarized in 
table 2.  
Table 2. Thirteen factors of which relationship with survival of patients were measures. 
 PS SSPS PS and SSPS 
factor P-value mortality risk P-value mortality risk P-value mortality risk 
age -  - - - 0.502 n/a 
sex -  - - - 0.951 n/a 
intubation- ventilation -  - - - <0.0001 2.06 
dyspnea 0.008 1.8 0.709 n/a -  - 
number of pill(s) -  - - - <0.0001 - 
epigastric pain 0.752 n/a 0.141 n/a 0.583 n/a 
heart burn 0.592 n/a 0.102 n/a -  - 
sore throat 0.004 -2.35 0.043* n/a* -  - 
thirst <0.0001 3.36 <0.0001 4.06 <0.0001 3.64 
nausea 0.001 -2.6 0.013 -1.6 -  - 
history of psychological disorder(s) - - - - 0.075 n/a 
history of suicidal attempt(s) - - - -- 0.177 n/a 
number of suicidal attempt(s) - - - - 0.482 n/a 
*Odds Ratio: 0.063-1.012, Risk Ratio: 0.135-1.141 
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In addition, frequency of mortality between the two 
groups was calculated in order to assess the efficacy of 
the newly proposed gastric lavage approach [suction of 
gastric contents, oral administration of sodium 
bicarbonate (three vials), potassium permanganate 
(1:10000) lavage and oral administration of sodium 
bicarbonate (again three vials)].  
From all 120 patients, 20 cases were intubated and 
artificially ventilated who all died, however, from the 
rest of 100 patients, 39 survived and 61 died. This 
suggests that the risk of mortality in patients who 
received intubation-ventilation is 2.06 times more  
than patients without intubation-ventilation (P<0.0001). 
In parallel, there were significant correlation  
between dyspnea and classic method of lavage (SP) and 
patients with dyspnea has more mortality of 1.8 time 
(P=0.014) in contrast with SSPS group in which no 
correlation between dyspnea and mortality was found 
(P=0.765).  
Additionally, patients with epigastric pain at hospital 
arrival time had no more risk of mortality than patients 
without (P=0.583). Because from 76 patients with 
epigastric pain, 28 died (36.8%) whereas from other 44 
pain-free patients, 20 patients died (45.5%). Moreover, 
no correlation was found between mortality and each of 
SP and SSPS (P-value was 0.481 and 0.116, 
respectively). Similarly, no correlation was found 
between existence of heart burn and two different 
treatment strategies (P=0.102 for SSPS and 0.592 for 
SP). On the contrary, nausea in both groups [SP 
(p=0.001) and SSPS (P=0.013)] indicates more chance 
of survival by 2.6 and 1.6 times, respectively. 
Furthermore, sore throat had significant correlation 
with mortality in SSPS (P=0.004) with 1.55 more time 
risk, however, this correlation did not exist in SP group 
(P=0.06).  
Interestingly, however, mortality risk was 3.64 times 
more in patients with thirst in comparison to another 
group (P<0.0001)  as 45 out of 58 patients with sense of 
thirst died (77.5%), however, only 13 out of 62 patients 
without sense of thirst died (21%). Moreover, in both 
groups of patients (SP and SSPS), there was a 
correlation between sense of thirst and mortality rate 
(P<0.0001) and patients with thirst had more 3.36 and 
4.06 times risk of mortality in SP and SSPS groups, 
respectively.  
According to the calculated P-value (0.075), past 
psychological disorder has no statistical impact on the 
mortality of patients as 29 out of 66 patients with 
psychological disorder and 32 out of 53 patients without 
psychological disorder survived.  
Table 3. Number of patients regarding number of ingested 
pill(s). 
ingested pill(s) 
n 
patients 
n 
patients died 
n (percent) 
1 14 3 (21.5%) 
2 35 12 (34%) 
3 55 27 (49%) 
4 16 16 (100%) 
Total 120 58 (43.8%) 
n: number 
 
 
Table 4. Number of dead and recovered patients for gender. 
 death 
n (percent) 
survival 
n (percent) 
total 
n (percent) 
Male  32 (48.5%) 34 (51.5%) 66 (100%) 
Femal  26 (48.1%) 28 (51.9%) 54 (100%) 
Total  58 (48.3%) 62 (51.7%) 120 (100%) 
n: number 
 
 
Furthermore, neither of prior suicidal history nor 
number of past suicidal attempts has significant impact 
on mortality (P=0.177 and 0.482, respectively) and 
patients with ALPP survive or die regardless of the three 
mentioned psychological-based parameters. Since from 
44 patients with suicidal attempt in their history, 25 
cases died (56%) and from 76 patients who had no 
previous suicidal attempt, 33 cases died (43%). One 
person (0.8%) had four suicidal attempts; four patients 
(3.3%) had committed suicide thrice, 13 patients 
(10.8%) twice and 26 patients (21.7%) once only. 
However and regarding the number of the ingested pills 
(Table 3), patients with more ingested tablets had more 
mortality (P<0.0001).  
Above all, comparison between two groups of 
patients who have been treated differently (PS versus 
SSPS) regarding mortality demonstrated that from 60 
patients of SSPS group, 36 recovered and 24 died, 
however, from 59 patients in SP group, only 25 cases 
recovered and the rest of 34 died. This suggests the new 
approach is more efficient in survival of patients, 
however, the P-value in comparison with the classic 
gastric lavage method was close to significant level 
(P=0.054) (Table 4). 
 
Discussion 
 
Aluminum phosphide poisoning (ALPP) is a common 
poisoning in Asia especially North-Central India, Iran, 
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Jordan and Morocco (1-5,13). The main cause of this 
phenomenon is its high utilization in grain storage and 
transportation facilities which mostly results in 
accidental poisoning. On the other hand, intentional 
poisoning for suicide is also common due to its 
accessibility, inexpensiveness and moreover, its fatal 
and irreversible effect, as has been reported since 
especially 80s (14). As no potent antidote has been 
developed, the only effective approach toward ALPP 
patients is supportive and critical care to balance blood 
PH, electrolytes and arterial blood pressure (6-10).  
On the contrary and as an Iranian local treatment 
strategy, oral administration of sodium bicarbonate in 
addition to potassium permanganate lavage is the 
currently acceptable first line treatment for ALPP 
(3,11,15). Additionally, administration of calcium 
gluconate and magnesium sulfate were considered for 
most of the patients. According to findings of Shadnia et 
al. there was significant difference between survivors 
and non-survivors of ALPP regarding blood 
concentration of bicarbonate (15). This emphasizes the 
importance of alkalization that is performed as standard 
approach in this referral center (15). This study is to 
improve the mentioned treatment strategy to establish a 
more effective approach through gastric lavage.  
First and foremost, we observed that SSPS lavage 
strategy results in less mortality than classic PS method 
which is promising, however, this difference was not 
quite statistically significant (P=0.054).  
Apart from that, we showed that the more tablets are 
ingested, the more mortality will occur. This is as same 
as Jaiswal et al. paper in which number of ingested 
tablets have been considered as the most important 
prognostic factor in survival of ALPP patients (7). 
Whereas, Singh et al. emphasized that dose of ingested 
drugs has no impact on prognosis of patients in contrast 
with number of vomits (16).  
From respiratory failure standpoint, our study 
proposed worse prognosis in patients with respiratory 
aid on time of hospital arrival as all of intubated-
ventilated patient died. Although this may first bring the 
negative impact of intubation-ventilation on prognosis, it 
should be borne in mind that this group of patients is of 
the poor general condition and death was inevitable in 
case no supportive care is regarded. Moreover, patients 
with dyspnea in SP had more risk of mortality while 
Jaiswal and colleagues reported only one patient with 
gasping who needed intubation among their 40 ALPP 
patients (7).  
Gastrointestinal manifestations recorded in our study 
were epigastric pain, heartburn and nausea. According to 
our findings, neither epigastric pain nor heartburn has 
impact on patients’ survival, whereas, patients with 
nausea had more survival chance for 1.6 and 2.6 more 
times in SSPS and SP groups respectively. Additionally, 
sense of thirst represents more risk of mortality in both 
groups (4.06 times in SSPS and 3.36 times in SP). We 
postulate that sense of thirst and nausea are symptoms of 
metabolic imbalance that occur in patients of worse 
general condition, however, epigastric pain and 
heartburn may relate to the personal sensitivity of gastric 
tissue to drugs.  
In addition, sore throat can be considered as a 
prognostic factor in whom SSPS was applied and 
represents 1.5 less chance of survival.  
According to our findings, 4-step-gastric lavage 
[suction of gastric contents using a 50 ml syringe, oral 
administration of three vials of sodium bicarbonate 
(7.5%), potassium permanganate (1:10000) lavage and 
again oral administration of three vials of sodium 
bicarbonate (SSPS)] is a more effective washing method 
than what has being used for many years in our center 
[potassium permanganate (1:10000) lavage and oral 
administration of three vials of sodium bicarbonate via 
gastric tube (PS)]. Moreover, indication of intubation-
ventilation, sense of thirst, sore throat and absence of 
nausea can be considered as reliable prognostic factors 
in survival of all ALPP patients.  
Nevertheless and according to insignificant different 
between the two method, more thorough studies should 
be conducted to assess its therapeutic efficacy. In 
conclusion, we demonstrated the efficacy of our new 
gastric lavage method (SSPS) over SP method which did 
not show statistical difference. In addition, indication for 
intubation-ventilation, sense of thirst, sore throat and 
absence of nausea are hypothesized to be reliable 
prognostic factors.  
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